These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 13661624)

  • 21. Quantitative studies on the clearing effect of heparin.
    EIBER HB; DANISHEFSKY I; CARR JJ
    JAMA; 1961 Jun; 176():871-3. PubMed ID: 13726040
    [No Abstract]   [Full Text] [Related]  

  • 22. Postheparin serum esterase activity compared with serum lipid levels in vivo.
    SLABOCHOVA Z; PLACER Z; NOVAK M
    Clin Chim Acta; 1960 Jul; 5():525-7. PubMed ID: 13831584
    [No Abstract]   [Full Text] [Related]  

  • 23. [The effect of heparin on the level of sugar and lipids in the blood in diabetic patients].
    Bozadzhieva ; V'rbanov G
    Probl Endokrinol Gormonoter; 1966; 12(4):45-8. PubMed ID: 6002013
    [No Abstract]   [Full Text] [Related]  

  • 24. Chylomicron dissolution; dosage and site of action of heparin.
    SWANK RL; LEVY SW
    Am J Physiol; 1952 Oct; 171(1):208-17. PubMed ID: 12985983
    [No Abstract]   [Full Text] [Related]  

  • 25. Sublingual heparin in hyperlipemia; a preliminary report.
    FULLER HL
    Angiology; 1958 Oct; 9(5):311-3. PubMed ID: 13583625
    [No Abstract]   [Full Text] [Related]  

  • 26. The role of heparin in the changes of lipid patterns during a single hemodialysis.
    Teraoka J; Matsui N; Nakagawa S; Takeuchi J
    Clin Nephrol; 1982 Feb; 17(2):96-9. PubMed ID: 6802545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Use of heparin in hyperlipemic conditions].
    GOVERS JJ
    Maandschr Kindergeneeskd; 1956 Apr; 24(4):131-9. PubMed ID: 13321084
    [No Abstract]   [Full Text] [Related]  

  • 28. [On lipoprotein lipase activity, serum lipids and the effect of heparin on the blood sugar level in atrophic liver cirrhosis and chronic hepatitis].
    Bosadjiewa E; Warbanow G; Markowski S; Beltschew L; Russinow E
    Z Gesamte Inn Med; 1967 Jul; 22(13):393-6. PubMed ID: 5595619
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of heparin on blood lipolytic and coagulation activity in patients with hypertensive disease].
    Oleĭnik NI
    Klin Med (Mosk); 1969 Jul; 47(7):75-9. PubMed ID: 5385094
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical study of the clearing factor].
    KAUFMANN H
    Presse Med (1893); 1955 Jul; 63(50):1045-6. PubMed ID: 13245703
    [No Abstract]   [Full Text] [Related]  

  • 31. [On a biological test for antilipemic derivatives of heparin].
    HERBAIN M
    Clin Chim Acta; 1960 Mar; 5():204-7. PubMed ID: 14401197
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of heparin and clofibrate on blood-serum lipid levels in patients with ischaemic heart disease.
    Haviar V; Riecanský L; Kusá O; Luknárová O
    Cor Vasa; 1972; 14(3):188-96. PubMed ID: 4344417
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of hyperlipemia & certain clearing factors on erythrosedimentation rate in autoplasma & in pectin in atherosclerotic subjects].
    RULLI V; ROSSI B
    Gazz Med Ital; 1959 May; 118(5):207-10. PubMed ID: 13664061
    [No Abstract]   [Full Text] [Related]  

  • 34. [Post-heparin plasmatic lipolytic activity (PHLA) and related pre-heparin plasmatic inhibitor in liver diseases].
    Donnini L
    Riv Crit Clin Med; 1967 Oct; 67(5):408-15. PubMed ID: 5604191
    [No Abstract]   [Full Text] [Related]  

  • 35. Systemic heparinization of uremic patients and its effects on blood lipids and on in vitro toxicity of the plasma.
    Wessel-Aas T; Christophersen B
    Clin Nephrol; 1982 Sep; 18(3):135-40. PubMed ID: 7140025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of clofibride in the rabbit or in normal man, at the beginning or after 15 days of treatment. Effects on plasma lipids in the hours following its administration during fasting, without heparin or during heparin-clearing factor induction].
    Elsair J; Drif M; Merad R; Denine R; Khelfat K; Benouniche N; Reggabi M; Alamir B
    Biomedicine; 1979 Nov; 30(5):249-56. PubMed ID: 518959
    [No Abstract]   [Full Text] [Related]  

  • 37. Acute lipidemic effect of calcium heparin in arteriosclerotic subjects.
    Ferlito S; Ricceri M; Platania M; Romano C; Zammataro M
    Panminerva Med; 1988; 30(4):257-61. PubMed ID: 3244481
    [No Abstract]   [Full Text] [Related]  

  • 38. Changes in serum lipids with the presence of various factors.
    Tesserommatis C; Tsopanakis C; Varonos D
    Beitr Infusionsther; 1988; 23():195-7. PubMed ID: 2484778
    [No Abstract]   [Full Text] [Related]  

  • 39. Morning vs evening effects of intrapulmonary administration of heparin in healthy men.
    Markiewicz A; Tausz B; Zahorska-Markiewicz B; Nawrot J
    Int J Clin Pharmacol Ther Toxicol; 1992 Oct; 30(10):400-4. PubMed ID: 1446957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The sites at which plasma clearing activity is produced and destroyed in the rat.
    JEFFRIES GH
    Q J Exp Physiol Cogn Med Sci; 1954; 39(4):261-70. PubMed ID: 13215769
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.